Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Peter Libby: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential
Peter Libby/LinkedIn
Oct 22, 2025, 06:16

Peter Libby: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential

Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Womens Hospital, shared a post on LinkedIn:

“What do we do to address cardiovascular risk in people with clonal hematopoiesis of indeterminate potential (CHIP) in the absence of clinical trial data? In our CHIP clinic, we practice aggressive preventive cardiology tuned to the particular CHIP and traditional risk factor profile of our patients in a transparent, shared decision-making mode. We summarize some of our approach in this Primer in JACC Cardiooncology paper.

We built this experience with serial fellows who worked with me in CHIP clinic, each now faculty members: Amy Lin UCSF, Aeron Small MGB/Harvard, and Ohad Oren Cleveland Clinic, who took the lead in this report. I’m proud of their successes! Nicholas Chiu is my current fellow, joining this lineage. Now we need to work together to generate the data to fill the evidence gap in managing CHIP!”

Title: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential: JACC: CardioOncology Short-Form Primer

Authors:  Ohad Oren, Aeron M. Small, Amy E. Lin, Peter Libby

 

 

Peter Libby: Managing Cardiovascular Risk in Clonal Hematopoiesis of Indeterminate Potential

Read full paper here.

Stay updated with Hemostasis Today.

Aeron M. Small Amy E. Lin Brigham and Women's Hospital clonal hematopoiesis of indeterminate potential (CHIP) Harvard Medical School Health Hematology Hemostasis Hemostasis Today Medicine Ohad Oren Peter Libby
NewsFeed